Showing results (891-900 of 4,514) with videos related to
Sort By:
Pageof 452
Future Oncology (London, England)|November 11, 2022
The impact of telemedicine on cancer care: real-world experience from a Peruvian institute during the COVID-19 pandemicKatia Roque, Rossana Ruiz, Iris Otoya-Fernandez, et al.Future Oncology (London, England)|February 23, 2023
Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancerPatrick M Forde, Jonathan Spicer, Shun Lu, et al.Future Oncology (London, England)|March 28, 2023
Relationships among clinicians are crucial to successful palliative care integration: a qualitative study in lung cancerDonald R Sullivan, Kelly C Vranas, Molly Delorit, et al.Future Oncology (London, England)|May 7, 2021
Inhibition of DNA damage response pathway using combination of DDR pathway inhibitors and radiation in treatment of acute lymphoblastic leukemia cellsMaryam Katoueezadeh, Niloofar Pilehvari, Ahmad Fatemi, et al.Future Oncology (London, England)|May 5, 2021
RAB1A regulates glioma cellular proliferation and invasion via the mTOR signaling pathway and epithelial-mesenchymal transitionBingcheng Ren, Le Wang, Yang Nan, et al.Future Oncology (London, England)|May 28, 2020
Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer?Priya HaysFuture Oncology (London, England)|May 30, 2020
WJOG10517G: a multicenter Phase II study of mFOLFOX6 in gastric cancer patients with severe peritoneal metastasesToshiki Masuishi, Takako Eguchi Nakajima, Kentaro Yamazaki, et al.Future Oncology (London, England)|May 14, 2021
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further linesAlessandro Dal Maso, Martina Lorenzi, Alessandra Ferro, et al.Future Oncology (London, England)|June 17, 2020
Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: rationale and clinical implicationGiuseppe Lamberti, Elisa Andrini, Monia Sisi, et al.Future Oncology (London, England)|June 6, 2020
Immunotherapy combinations for the treatment of patients with solid tumorsMaria Virginia Bluthgen, Neus Basté, Gonzalo RecondoPageof 452